Author

Cristina Poveda

Baylor College of MedicineORCID 0000-0003-0361-2232Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:host-pathogen & immune response· 1 Assay:protein structure· 1 Organism:yeast· 1

Frequent Co-Authors

Jeroen B. K. PolletiD· 3 shared María Elena BottazziiD· 3 shared Peter Jay HoteziD· 3 shared Bin ZhaniD· 2 shared Brian P. KeeganiD· 2 shared Jason T. KimataiD· 2 shared Junfei WeiiD· 2 shared Jungsoon LeeiD· 2 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMolecular Biology

Jeroen B. K. PolletORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

PathologyPLoS neglected tropical diseasesPeer-reviewedNov 21, 2023

The impact of vaccine-linked chemotherapy on liver health in a mouse model of chronic Trypanosoma cruzi infection

Duc Minh Nguyen, Cristina Poveda, Jeroen B. K. Pollet…·Kathryn Marie Jones

This study evaluates the impact of vaccine-linked chemotherapy on liver health in a mouse model of chronic Trypanosoma cruzi infection, finding that the treatment better preserves liver health compared to curative doses of benznidazole.

9 citations

mousebulk RNA-seq

𝕏 PostBluesky

Molecular BiologyVaccinePeer-reviewedMay 8, 2022

Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern

Jeroen B. K. Pollet, Ulrich Strych, Wen‐Hsiang Chen…·María Elena Bottazzi

This study evaluates a SARS-CoV-2 RBD subunit vaccine in mice, showing that adding CpG enhances immune response and neutralizing antibodies against multiple variants.

42 citationstop 3%

mouseexperimental assay

𝕏 PostBluesky

Molecular BiologyProtein Expression and PurificationPeer-reviewedOct 21, 2021

Yeast-expressed Recombinant SARS-CoV-2 Receptor Binding Domain, RBD203-N1 as a COVID-19 Protein Vaccine Candidate

Wen‐Hsiang Chen, Jeroen B. K. Pollet, Ulrich Strych…·María Elena Bottazzi

This paper describes the development of a recombinant SARS-CoV-2 RBD vaccine candidate produced in yeast, showing high purity, stability, and immunogenicity in mice.

49 citations

yeastprotein structure

𝕏 PostBluesky